Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
Medullary thyroid carcinoma.
Griebeler ML, Gharib H, Thompson GB.
Endocr Pract. 2013 Jul-Aug;19(4):703-11. doi: 10.4158/EP12430.RA.
Familial non-medullary thyroid carcinoma: an update.
Nosé V.
Endocr Pathol. 2008 Winter;19(4):226-40. doi: 10.1007/s12022-008-9045-z.
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA, Nosé V, Sadow PM.
Endocr Pathol. 2021 Mar;32(1):35-43. doi: 10.1007/s12022-021-09664-3. Epub 2021 Jan 25.
[Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF, Poterico Rojas JA, Barrionuevo Cornejo C, Casavilca Zambrano S, Pinedo Cárdenas A, Quispe Santibañez I, Castro Mujica MDC.
Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 12;75(4):303-309. doi: 10.31053/1853.0605.v75.n4.20947.
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Matrone A, Gambale C, Prete A, Elisei R.
Front Endocrinol (Lausanne). 2022 Mar 29;13:864253. doi: 10.3389/fendo.2022.864253. eCollection 2022.
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance.
Saltiki K, Simeakis G, Karapanou O, Paschou SA, Alevizaki M.
Endocrine. 2023 Jun;80(3):570-579. doi: 10.1007/s12020-022-03296-1. Epub 2023 Jan 10.
Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.
Sánchez-Ares M, Cameselle-García S, Abdulkader-Nallib I, Rodríguez-Carnero G, Beiras-Sarasquete C, Puñal-Rodríguez JA, Cameselle-Teijeiro JM.
Front Endocrinol (Lausanne). 2022 Feb 28;13:829103. doi: 10.3389/fendo.2022.829103. eCollection 2022.
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades.
Hensley SG, Hu MI, Bassett RL, Ying AK, Zafereo ME, Perrier ND, Busaidy NL, Hyde SM, Grubbs EG, Waguespack SG.
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2256-2268. doi: 10.1210/clinem/dgae133.
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
Figlioli G, Landi S, Romei C, Elisei R, Gemignani F.
Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8.
